Araghi F, Dadkhahfar S, Robati R, Tabary M, Shahidi-Dadras M
Clin Exp Med. 2022; 23(4):1045-1054.
PMID: 35925475
DOI: 10.1007/s10238-022-00855-8.
Zhong H, Liu Y, Xu Z, Liang P, Yang H, Zhang X
Front Immunol. 2018; 9:35.
PMID: 29441062
PMC: 5797539.
DOI: 10.3389/fimmu.2018.00035.
Clarke S
Immunol Res. 2008; 41(3):203-16.
PMID: 18592142
DOI: 10.1007/s12026-008-8023-3.
Nicholas M, Dooley M, Hogan S, Anolik J, Looney J, Sanz I
Clin Immunol. 2007; 126(2):189-201.
PMID: 18077220
PMC: 2812414.
DOI: 10.1016/j.clim.2007.10.004.
Culton D, Nicholas M, Bunch D, Zhen Q, Kepler T, Dooley M
J Clin Immunol. 2006; 27(1):53-68.
PMID: 17195045
DOI: 10.1007/s10875-006-9051-1.
B lymphocyte stimulator (BLyS) isoforms in systemic lupus erythematosus: disease activity correlates better with blood leukocyte BLyS mRNA levels than with plasma BLyS protein levels.
Collins C, Gavin A, Migone T, Hilbert D, Nemazee D, Stohl W
Arthritis Res Ther. 2005; 8(1):R6.
PMID: 16356193
PMC: 1526545.
DOI: 10.1186/ar1855.
Urine free light chains in SLE: clonal markers of B-cell activity and potential link to in vivo secreted Ig.
Hopper J, Golbus J, Meyer C, Ferrer G
J Clin Immunol. 2000; 20(2):123-37.
PMID: 10821464
DOI: 10.1023/a:1006686514743.
Genetic dissection of lupus nephritis in murine models of SLE.
Wakeland E, Morel L, Mohan C, Yui M
J Clin Immunol. 1997; 17(4):272-81.
PMID: 9258766
DOI: 10.1023/a:1027370514198.
Complement receptor expression and activation of the complement cascade on B lymphocytes from patients with systemic lupus erythematosus (SLE).
Marquart H, Svendsen A, Rasmussen J, Nielsen C, Junker P, Svehag S
Clin Exp Immunol. 1995; 101(1):60-5.
PMID: 7621593
PMC: 1553287.
DOI: 10.1111/j.1365-2249.1995.tb02277.x.
Antibodies to polyadenylic acid in patients with myasthenia gravis.
Fischbach M, Lindstrom J, Talal N
Clin Exp Immunol. 1981; 43(1):73-9.
PMID: 7249396
PMC: 1537129.
Alterations in immunoregulatory T cell subsets in active systemic lupus erythematosus.
Morimoto C, Reinherz E, Schlossman S, Schur P, Mills J, Steinberg A
J Clin Invest. 1980; 66(5):1171-4.
PMID: 7000827
PMC: 371557.
DOI: 10.1172/JCI109948.
Defective B cell function in systemic lupus erythematosus.
Pelton B, DENMAN A
Clin Exp Immunol. 1982; 48(3):513-8.
PMID: 6981471
PMC: 1536611.
Lymphocyte studies in pemphigus.
Ahmed A
Arch Dermatol Res. 1981; 271(1):111-5.
PMID: 6975086
DOI: 10.1007/BF00417395.
Anti-Ia reactivity in sera from patients with systemic lupus erythematosus.
Okudaira K, Searles R, Ceuppens J, Goodwin J, Williams Jr R
J Clin Invest. 1982; 69(1):17-24.
PMID: 6947981
PMC: 371163.
DOI: 10.1172/jci110428.
Immunoglobulin production in vitro by peripheral blood lymphocytes in systemic lupus erythematosus: helper T cell defect and B cell hyperreactivity.
Tan P, Pang G, Wilson J
Clin Exp Immunol. 1981; 44(3):548-54.
PMID: 6799237
PMC: 1537314.
In vitro antibody response of human lymphocytes.
Heijnen C, Uytdehaag F, Ballieux R
Springer Semin Immunopathol. 1980; 3(1):63-92.
PMID: 6792726
DOI: 10.1007/BF00199926.
Spontaneous plaque forming cells in the peripheral blood of patients with systemic lupus erythematosus.
WANGEL A, Milton A, Egan J
Clin Exp Immunol. 1982; 49(1):41-9.
PMID: 6751633
PMC: 1536661.
Injection of mouse thyroglobulin and/or adult thymectomy do not break tolerance to thyroglobulin during the lupus like graft versus host disease in mice.
Kong Y, Rose N, Kimura M, Gleichmann E
Clin Exp Immunol. 1984; 55(3):525-34.
PMID: 6705266
PMC: 1535914.
Depressed primary in vitro antibody response in untreated systemic lupus erythematosus. T helper cell defect and lack of defective suppressor cell function.
Delfraissy J, Segond P, Galanaud P, Wallon C, MASSIAS P, Dormont J
J Clin Invest. 1980; 66(1):141-8.
PMID: 6447163
PMC: 371515.
DOI: 10.1172/JCI109827.
Suppressor cell defect in SLE: relationship to native DNA binding.
Krakauer R, Clough J, Alexander T, Sundeen J, Sauder D
Clin Exp Immunol. 1980; 40(1):72-6.
PMID: 6446432
PMC: 1536952.